Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stimulant medications for cognitive enhancement in healthy volunteers
ACTRN12617001544369Phase 4Completed
- Sponsor
- University of Melbourne
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of dextroamphetamine, methylphenidate and modafinil (4 arms), sponsored by University of Melbourne. Primary endpoint: Complex optimisation task accuracy. Started Nov 2017; status: completed.
02
Drugs
dextroamphetaminemethylphenidatemodafinil
Beyond the preview
Go deeper on ACTRN12617001544369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001544369.